FDA Amps Up Postmarket Focus With String of Public Meetings

Devices & Diagnostics Letter
Devicemakers will have an opportunity to air their concerns about the FDA’s postmarket surveillance system at a Sept. 10 public meeting in Greenbelt, Md.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00